Compounds for the treatment of atropic vaginitis

Bibliography

• Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000;96:351-8. Nelson HD, Haney E, Humphrey L, et al. Management of menopause-related symptoms. Evidence report/technology assessment no. 120. Rockville, MD: Agency for Healthcare Research and Quality, March 2005. (AHRQ publication no. 05-E016-2))
   PubMedGoogle Scholar
• Rymer J, Morris EP. Extracts from “clinical evidence”: menopausal symptoms. BMJ 2000;321:1516-9
   PubMedGoogle Scholar
• Kelley C. Estrogen and its effect on vaginal atrophy in post-menopausal women. Urol Nurs 2007;27(1):40-5
   PubMedGoogle Scholar
• Woods NF, Mitchell ES. Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women's lives. Am J Med 2005;118(Suppl 12B):14
   PubMed Web of Science ®Google Scholar
• Bachmann GA, Nevadunsky NS. Diagnosis and treatment of atrophic vaginitis. Am Fam Physician 2000;61:3090
   PubMed Web of Science ®Google Scholar
• Sarrel PM. Effects of hormone replacement therapy on sexual psychophysiology and behavior in postmenopause. J Womens Health Gend Based Med 2000;9:S25-32
   PubMedGoogle Scholar
• Freedman MA. Quality of life and menopause: the role of estrogen. J Womens Health (Larchmt) 2002;11:703-18
   PubMed Web of Science ®Google Scholar
• Bachmann GA, Leiblum SR, Grill J. Brief sexual inquiry in gynecological practice. Obstet Gyn 1989;73:425-7
   PubMed Web of Science ®Google Scholar
• Castelo-Branco C, Cancelo MJ, Villero J, et al. Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas 2005;52(Suppl 1):S46
   PubMed Web of Science ®Google Scholar
• Gorodeski GI. Aging and estrogen effects on transcervical-transvaginal epithelial permeability. J Clin Endocrinol Metab 2005;90(1):345-51
   PubMedGoogle Scholar
• Cotreau MM, Chennathukuzhi VM, Harris HA, et al. A study of 17beta-estradiol-regulated genes in the vagina of postmenopausal women with vaginal atrophy. Maturitas 2007;58(4):366-76
   PubMed Web of Science ®Google Scholar
• Goldstein I, Alexander JL. Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women. J Sex Med 2005;3(2 Suppl):154-65
   Web of Science ®Google Scholar
• Society of Obstetricians and Gynaecologists of Canada. SOGC clinical practice guidelines. The detection and management of vaginal atrophy. Int J Gynaecol Obstet 2005;88(2):222-8
   PubMed Web of Science ®Google Scholar
• Johnston SL, Farrell SA, Bouchard C, et al. SOGC Joint Committee-Clinical Practice Gynaecology and Urogynaecology.The detection and management of vaginal atrophy. J Obstet Gynaecol Can 2004;26(5):503-15
   PubMedGoogle Scholar
• Lepargneur JP, Rousseau V. Protective role of the Doderleïn flora. J Gynecol Obstet Biol Reprod (Paris) 2002;31(5):485-94
   PubMedGoogle Scholar
• Galhardo CL, Soares JM Jr, Simões RS, et al. Estrogen effects on the vaginal pH, flora and cytology in late postmenopause after a long period without hormone therapy. Clin Exp Obstet Gynecol 2006;33(2):85-9
   PubMed Web of Science ®Google Scholar
• Willhite LA, O'Connell MB. Urogenital atrophy: prevention and treatment. Pharmacotherapy 2001;21(4):464-80
   PubMed Web of Science ®Google Scholar
• Varras M, Polyzos D, Akrivis Ch. Effects of tamoxifen on the human female genital tract: review of the literature. Eur J Gynaecol Oncol 2003;24(3-4):258-68
   PubMedGoogle Scholar
• Valente PT, Schantz HD, Trabal JF. Cytologic changes in cervical smears associated with prolonged use of depot-medroxyprogesterone acetate. Cancer 1998;84(6):328-34
   PubMedGoogle Scholar
• Wisniewski PM, Wilkinson EJ. Postpartum vaginal atrophy. Am J Obstet Gynecol 1991;165(4 Pt 2):1249-54
   PubMed Web of Science ®Google Scholar
• Mikkelsen TF, Graff-Iversen S, Sundby J, et al. Early menopause, association with tobacco smoking, coffee consumption and other lifestyle factors: a cross-sectional study. BMC Public Health 2007;7:149
   PubMed Web of Science ®Google Scholar
• Baron JA, La Vecchia C, Levi F. The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol 1990;162:502-14
   PubMed Web of Science ®Google Scholar
• Karamanidis D, Tamiolakis D, Koutsougeras G, et al. Cigarette smoking and the degree of maturation of the vaginal squamous epithelium in postmenopausal women. Clin Exp Obstet Gynecol 2001;28(4):274-6
   PubMedGoogle Scholar
• Monfrecola G, Riccio G, Savarese C, et al. The acute effect of smoking on cutaneous microcirculation blood flow in habitual smokers and nonsmokers. Dermatology 1998;197(2):115-8
   PubMed Web of Science ®Google Scholar
• Johnston SL, Farrell SA, Bouchard C, et al. SOGC Joint Committee-Clinical Practice Gynaecology and Urogynaecology. The detection and management of vaginal atrophy. J Obstet Gynaecol Can 2004;26(5):503-15
   PubMedGoogle Scholar
• Johnston SL, Farrell SA, Bouchard C, et al. The detection and management of vaginal atrophy. J Obstet Gynaecol Can 2004;26:503
   PubMedGoogle Scholar
• O'Connell TX, Nathan LS, Satmary WA, et al. Non-neoplastic epithelial disorders of the vulva. Am Fam Physician 2008;77(3):321-6
   PubMed Web of Science ®Google Scholar
• Willhite LA, O'Connell MB Pharmacotherapy. Urogenital atrophy: prevention and treatment. 2001;21(4):464-80
   Google Scholar
• Selvaggi SM. Atrophic vaginitis versus invasive squamous cell carcinoma on ThinPrep cytology: can the background be reliably distinguished? Diagn Cytopathol 2002;27:362
   PubMedGoogle Scholar
• Nucci P. Patent Number US5063930; 1990
   Google Scholar
• Gupta S, Kumar N, Singhal N, et al. Cytohormonal and morphological alterations in cervicovaginal smears of postmenopausal women on hormone replacement therapy. Diagn Cytopathol 2006;34(10):676-81
   PubMed Web of Science ®Google Scholar
• Kelley C. Estrogen and its effect on vaginal atrophy in post-menopausal women. Urol Nurs 2007;27(1):40-5
   PubMedGoogle Scholar
• Wilson JD, Lee RA, Balen AH, Rutherford AJ. Bacterial vaginal flora in relation to changing oestrogen levels. Int J STD AIDS 2007;18(5):308-11
   PubMed Web of Science ®Google Scholar
• Wyeth Corp. Gast M. Patent Number WO2007118135; 2007
   Google Scholar
• Willhite LA, O'Connell MB. Urogenital atrophy: prevention and treatment. Pharmacotherapy 2001;21:464-80
   PubMed Web of Science ®Google Scholar
• Gast M. Helzner E. US2007/0238713 A1; 2007
   Google Scholar
• Simon JA, Bouchard C, Waldbaum A, et al. Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial. Obstet Gynecol 2007;109(3):588-96
   PubMed Web of Science ®Google Scholar
• Mandel FP, Geola, FL Meldrum DR, et al. Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women. J Clin Endocrinol Metab 1983;57:133
   PubMed Web of Science ®Google Scholar
• Cardozo L, Bachmann, G McClish D, et al. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1998;92:722
   PubMed Web of Science ®Google Scholar
• Notelovitz M, Funk S, Nanavati N, et al. Estradiol absorption from vaginal tablets in postmenopausal women. Obstet Gynecol 2002;99:556
   PubMed Web of Science ®Google Scholar
• Henriksson L, Stjernquist M, Boquist L, et al. A one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging. Am J Obstet Gynecol 1996;174:85
   PubMed Web of Science ®Google Scholar
• Utian WH, Archer DF, Bachmann GA, et al. Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society. 2008;15(4 Pt 1):584-602
   Google Scholar
• Baker VL. Alternatives to oral estrogen replacement: Transdermal patches, percutaneous gels, vaginal creams and rings, implants, and other methods of delivery. Obstet Gynecol Clin North Am 1994;21:271
   PubMed Web of Science ®Google Scholar
• Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 2006(4):CD001500
   PubMedGoogle Scholar
• Kunihiko M, Kenichi H, Masahiro Y. U.S. Classification 424449000; 514170000; 2004
   Google Scholar
• Steven Cummings, Herman Ellman, Bruce Ettinger Patent number: US5891868;1997
   Google Scholar
• Kalogirou D, Antoniou G, Karakitsos P, et al. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with alevonorgestrel-releasing IUD: clinical findings and endometrial response. Int J Fertil Menopausal Stud 1996;41(6):522-7
   PubMed Web of Science ®Google Scholar
• Johnson SR, Ettinger B, Macer JL, et al. Uterine and vaginal effects of unopposed ultralow-dose transdermal estradiol. Obstet Gynecol 2005;105(4):779-87
   PubMed Web of Science ®Google Scholar
• Jung K. Patent Number US20070009470; 2006
   Google Scholar
• Koch K, Kvorning I. Patent number: US7018992; 2001
   Google Scholar
• Bachmann G, Lobo RA, Gut R, et al. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Obstet Gynecol 2008;111(1):67-76
   PubMed Web of Science ®Google Scholar
• Santen RJ, Pinkerton JV, Conaway M, et al. Treatment of urogenital atrophy with low-dose estradiol: preliminary results. Menopause 2002;9:179
   PubMed Web of Science ®Google Scholar
• Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 2003;CD001500
   PubMedGoogle Scholar
• Alza Corp. Patrick W. Patent Number US4629449; 1986
   Google Scholar
• Gupta P, Ozel B, Stanczyk FZ, et al. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status. Menopause 2008;15(1):94-7
   PubMed Web of Science ®Google Scholar
• Weisberg E, Ayton R, Darling G, et al. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet. Climacteric 2005;8:83
   PubMed Web of Science ®Google Scholar
• Casper F, Petri E. Local treatment of urogenital atrophy with an estradiol-releasing vaginal ring: acomparative and a placebo-controlled multicenter study. Vaginal Ring Study Group. Int Urogynecol J Pelvic Floor Dysfunct 1999;10(3):171-6
   PubMedGoogle Scholar
• Shephard BD. Low- vs high-dose estradiol vaginal ring in treatment of sexual difficulties. JAMA 2007;297(19):2076
   PubMedGoogle Scholar
• Henriksson L, Stjernquist M, Boquist L, et al. A one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging. Am J Obstet Gynecol 1996;174:85
   PubMed Web of Science ®Google Scholar
• Speroff L. Efficacy and tolerability of a novel estradiol vaginal ring for relief of menopausal symptoms. Obstet Gynecol 2003;102(4):823-34
   PubMed Web of Science ®Google Scholar
• Dezarnaulds G, Fraser IS. Vaginal ring delivery of hormone replacement therapy-a review. Expert Opin Pharmacother 2003;4(2):201-12
   PubMed Web of Science ®Google Scholar
• Kendall A, Dowsett M, Folkerd E, et al. Caution: Vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors. Ann Oncol 2006;17:584
   PubMed Web of Science ®Google Scholar
• Santen RJ, Pinkerton JV, Conaway M, et al. Treatment of urogenital atrophy with low-dose estradiol: preliminary results. Menopause 2002;9:179
   PubMed Web of Science ®Google Scholar
• Novo Nordisk AS. Koch K, Kvorning I. Patent Number US2005209209; 2005
   Google Scholar
• Raymundo N, Yu-cheng B, Zi-yan H, et al. Treatment of atrophic vaginitis with topical conjugated equine estrogens in postmenopausal Asian women. Climacteric 2004;7(3):312-8
   PubMed Web of Science ®Google Scholar
• Innothera Lab SA. Meignant C. Patent Number US6060077; 2000
   Google Scholar
• Friedman D, Besonov A, Tamarkin D, et al. US. Classification 424401000; 2005
   Google Scholar
• Rioux JE, Devlin C, Gelfand MM, et al. 17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis. Menopause 2000;7(3):156-61
   PubMed Web of Science ®Google Scholar
• Palacios S, Castelo-Branco C, Cancelo MJ, Vázquez F. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy. Maturitas 2005;50(2):98-104
   PubMed Web of Science ®Google Scholar
• de Haan P, Lambregts T, Morita R, et al. Patent number: US6399594; 1999
   Google Scholar
• Modelska H, Cummings S. Tibolone for Postmenopausal Women: Systematic Review of Randomized Trials. Clin Endocrinol Metab 2002;87(1):16-23
   Google Scholar
• Kenemans P, Speroff L. International Tibolone Consensus Group. Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group. Maturitas 2005;51(1):21-8
   PubMed Web of Science ®Google Scholar
• Laan E, van Lunsen RH, Everaerd W. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women. Climacteric 2001;4(1):28-41
   PubMedGoogle Scholar
• Swanson SG, Drosman S, Helmond FA, et al. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind,placebo-controlled study. Menopause 2006;13(6):917-25
   PubMed Web of Science ®Google Scholar
• The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society. Menopause 2007;14:357
   Web of Science ®Google Scholar
• Polytherapeutics, Inc. Shah; Kishore R. (Bridgewater, NJ) Patent number: US5942243; 1998
   Google Scholar
• Nachtigall LE. Comparative study: Replens versus local estrogen in menopausal women. Fertil Steril 1994;61:178
   PubMed Web of Science ®Google Scholar
• van der Laak JA, de Bie LM, de Leeuw H, et al. The effect of Replens on vaginal cytology in the treatment of postmenopausal atrophy: cytomorphology versus computerised cytometry. Clin Pathol 2002;55(6):446-51
   PubMed Web of Science ®Google Scholar
• Rosenberg PK, Potini C. US Classification 424488000; 2004
   Google Scholar
• McNeil-PPC Inc, Ahmad N, Patel K, Huseth M. Patent number: US6139848; 2000
   Google Scholar
• Gupta V, Gupta V, Nikolic B. U.S. Classification 424443000; 2006
   Google Scholar
• Bottoni G, Maffei P, Sforzini A, Federici M, Caeamella C, Rossi S, Viscomi G Patent Number WO2006131262; 2006
   Google Scholar
• Columbia Lab Inc. Robinson Joseph. Patent Number GR3015011T; 1995
   Google Scholar
• LMG - P 17630 L plantarum Patent Number. EP 1046713 A2; 2000
   Google Scholar
• McClafferty V. Patent Number GB2310375; 1997
   Google Scholar
• Manonai J, Songchitsomboon S, Chanda K, et al. The effect of a soy-rich diet on urogenital atrophy: a randomized, cross-over trial. Maturitas 2006;54(2):135-40
   PubMed Web of Science ®Google Scholar
• D'Anna R, Cannata ML, Atteritano M, et al. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study. Menopause 2007;14(4):648-55
   PubMed Web of Science ®Google Scholar
• Reed SD, Newton KM, LaCroix AZ, et al. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study. Menopause 2008;15(1):51-8
   PubMed Web of Science ®Google Scholar
• Egyptian Natural Oil; South Egypt Drug Ind Co. Nabil S. Patent Number US2004170710; 2004
   Google Scholar
• Egyptian Natural Oil; South Egypt Drug Ind Co. Nabil S. Patent Number US2004170710; 2004
   Google Scholar
• Bouchard C. Herbal alternatives as substitutes for hormone therapy in urogenital atrophy:scientific evidence is needed. Menopause 2008;15(1):12-3
   PubMedGoogle Scholar
• Leiblum S, Bachmann G, Kemmann E, et al. Vaginal atrophy in the postmenopausal woman: the importance of sexual activity and hormones. JAMA 1983;249:2195
   PubMed Web of Science ®Google Scholar
• Cecil PM, Darcy S Vernon SD. Patent Number CA2162260; 1994
   Google Scholar
• Bikle D, Teichert A, Hawker N, et al. Sequential regulation of keratinocyte differentiation by 1,25(OH)2D3, VDR, andits coregulators. J Steroid Biochem Mol Biol 2007;103(3-5):396-404
   PubMed Web of Science ®Google Scholar
• Kutuzova GD, Deluca HF. Gene expression profiles in rat intestine identify pathways for 1,25-dihydroxyvitamin D(3) stimulated calcium absorption and clarify its immunomodulatory properties. Arch Biochem Biophys 2004;432(2):152-66
   PubMed Web of Science ®Google Scholar
• Abban G, Yildirim NB, Jetten AM. Regulation of the vitamin D receptor and cornifin beta expression in vaginal epithelium of the rats through vitamin d3. Eur J Histochem 2008;52(2):107-14
   PubMedGoogle Scholar
• Jetten AM, De Luca LM, Nelson K, et al. Regulation of cornifin alpha expression in the vaginal and uterine epithelium by estrogen and retinoic acid. Mol Cell Endocrinol 1996;123(1):7-15
   PubMedGoogle Scholar
• Holick M. U.S. Classification 514012000; 2003
   Google Scholar
• Endorech Inc. Fernand L. Patent Number US2003065008; 2003
   Google Scholar